A Window of Opportunity Study of Black Raspberry for Patients With HNSCC
Status:
Not yet recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this phase 0 Window of Opportunity study is to have subjects with Head and
Neck Squamous Cell Carcinoma (HNSCC) receive same dosage of Black Raspberry Extract between
their cancer diagnosis and standard treatment (surgery). Tumor biopsies and research blood
before and after the investigational treatment (Black Raspberry Extract lozenges) are
collected for translational research. The investigational treatment is kept short to avoid
delaying standard treatment.